Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities TRVI - Trevi Therapeutics, Inc.
-7.91 M
LAST VALUE
-17.51%
2 YEAR CAGR
-365.28%
5 YEAR CAGR
0.00%
10 YEAR CAGR